Ireland
--:--IST
Recruiting Not applicable

Continuous Erector Spinae Block Versus Continuous Edge of Laminar Block on The Quality of Analgesia and Diaphragmatic Excursion in Patients With Multiple Rib Fractures

NCT07069101 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-11-01
Last updated
2025-07-20

Condition(s) studied

Erector Spinae BlockEdge of Laminar BlockAnalgesiaDiaphragmatic ExcursionMultiple Rib Fractures

Investigational drug(s) / intervention(s)

Erector spinae blockEdge of lamina block

Erector spinae block: Patients will receive continuous ipsilateral erector spinae plane block.

Edge of lamina block: Patients will receive continuous ipsilateral edge of laminar block.

Study summary

This prospective randomized clinical trial aims to compare the effect of continuous erector spinae plane block versus continuous edge of laminar block on the quality of analgesia and diaphragmatic excursion in patients with unilateral traumatic multiple rib fractures.

Eligibility

Sex
ALL
Min age
21 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 21 and 65 years. * Both sexes. * With unilateral traumatic multiple fracture ribs (≥ 3), admitted to the surgical intensive care unit within the first day of trauma. Exclusion Criteria: * Patients' rejection. * Body mass index ≥ 35 (kg/m2). * Bleeding and Coagulation disorders. * Known hypersensitivity to the study drugs. * Vertebral deformity. * Respiratory, cardiac, renal or hepatic dysfunction. * Patients with major trauma involving extra-thoracic structures (e.g., head, spine, pelvis, and abdominal visceral injuries). * Mental or cognitive dysfunction, * History of chronic analgesic or drug abuse. * Local infection at the site of the block.

Primary outcome measure(s)

  • Total morphine consumption — 4 days postoperatively
    If the Numeric Rating Scale (NRS) is 4 or more IV morphine 3mg will be given.

Trial sites (1)

FacilityCityRegionStatus
Tanta University Tanta El-Gharbia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07069101 on ClinicalTrials.gov ↗ ← All trials in Egypt